​

Funding Round

Series B - Cadent Therapeutics

Series B - Cadent Therapeutics

Investment Firm

Overview

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

Announced Date

Apr 29, 2020

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorAccess Industries
Participant InvestorClal Biotechnology Industries
Participant InvestorNovartis Institutes for Biomedical Research
Participant InvestorAtlas Venture
Participant InvestorQiming Venture Partners

Round Details and Background

Cadent Therapeutics raised $15000000 on 2020-04-29 in Series B

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 29, 2020
Series B - Cadent Therapeutics
6-15.0M
Jun 28, 2010
Seed Round - Cadent Therapeutics
1-250.0K
Jun 21, 2013
Series A - Cadent Therapeutics
2-6.0M
Feb 16, 2012
Series A - Cadent Therapeutics
2-5.4M

Recent Activity

There is no recent news or activity for this profile.